RISK SURVEILLANCE OF MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA IN WATER AND  PLASMID RELATEDNESS WITH CLINICAL STRAINS  IN ABEOKUTA, SOUTHWEST NIGERIA by SHITTU, O B et al.
RISK SURVEILLANCE OF MULTIDRUG RESISTANT 
PSEUDOMONAS AERUGINOSA IN WATER AND  
PLASMID RELATEDNESS WITH CLINICAL STRAINS  
IN ABEOKUTA, SOUTHWEST NIGERIA 
 
*1O. B. SHITTU,  1S.A. ADENIRAN,  1O. R.AFOLABI AND 2S.O. SAM-WOBO  
 
1Department of Microbiology, Federal University of Agriculture, Abeokuta, Nigeria. 
2Department of Biological Sciences, Federal University of Agriculture, Abeokuta, Nigeria. 
*Corresponding author:olufunke_b@yahoo.com Tel:  +2348033532640 
Pseudomonas aeruginosa has been an important 
pathogen in nosocomial infections (Rutala 
and Weber, 1997; Blondel-Hill et al., 2009).  
Water is one of the principal agents of cross 
contamination in the clinical environment.   
It is associated with water taps, sinks, traps, 
and bath toys (Buttery et al., 1998; Reuter et 
al., 2002).    Pseudomonas aeruginosa can also 
contaminate catheters and intravenous lines 
ABSTRACT 
Pseudomonas aeruginosa as an opportunistic pathogen has been a subject of investigation due its 
intrinsic drug resistance.   Its frequent presence in drinking, domestic and recreational water highlights 
its significance to public health.   This study was aimed at risk surveillance of multidrug resistant envi-
ronmental P. aeruginosa in water and their plasmid relatedness with clinical strains in Abeokuta, 
southwestern Nigeria.   A total of forty-one (41) strains with prevalence: well water (29.3%); swimming 
pool (22.0%) hospital storage tank (19.5%); tap water (14.6%); sachet water (12.2%); and bottled wa-
ter (2.4%) respectively were isolated from two hundred and eighty eight (288) water samples and were 
compared with 43 clinical strains from wound (37.3%), blood (11.6%), ear swab (20.9%)  and urine 
(20.9%)  and eye swab (9.3%).     Both environmental and clinical strains were all multidrug resistant, 
though with different plasmid profile.  Plasmid with molecular weight size of 2010bp was detected in 
only 1 (2.5%) out of the 41 environmental strains as against 9 (20.93%) of the 43 clinical strains hav-
ing between 22520-23130bp molecular weight.  All strains harboring plasmid were resistant to varied 
types of more than seven drugs out of the eleven tested (gentamycin 10µg, erythromycin 15µg, ampi-
cillin 10µg, augmentin 10µg, cotrimoxazole 25µg, tetracycline 30µg, streptomycin 10µg, ciprofloxacin 
5µg, cloxacillin 5µg, amoxicillin 25µg, and cefuroxime 30µg).  Strains without plasmid were also multi-
drug resistant.  This finding would be important in the control of multidrug resistant Pseudomonas 
aeruginosa infection in Nigeria.   
 
KEY WORDS: Pseudomonas aeruginosa; multidrug resistance; drinking water, recreational water; 
Plasmid profile  
INTRODUCTION 
Pseudomonas aeruginosa is capable of causing a 
variety of life threatening human infections 
(Aliaga et al., 2002).   Infections caused by 
Pseudomonas aeruginosa are particularly prob-
lematic because the organism is inherently 
resistant to many drug classes and is able to 
acquire resistance to all effective antimicro-
bial drugs (Goldberg, 2000).   
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(IVs) (Edgeworth et al., 1999).   Ventilator-
associated pneumonia (VAP) is frequently 
caused by P. aeruginosa (Bergmanns et al., 
1998).    
 
Frequent presence of P. aeruginosa in recrea-
tional and drinking water also highlights its 
significance to public health.      Zichichi et 
al. (2000) reported P. aeruginosa in folliculitis 
after shower/bath exposure and Barben et. 
al. (2005) reported its occurrence in bath-
room of patients with cystic fibrosis.   Pseu-
domonas aeruginosa is also naturally found in 
many types of drinking water (Hardalo and 
Edberg, 1997; Hirulkar and Soni,  2011), 
drinking water biofilms (Moritz et al., 2010; 
Waines et al., 2011), hot tubs (Dulabon et al., 
2009), mobile bathing service (Sakurai-
Komada et al., 2006) and swimming pools 
(Mena and Gerba, 2009; Tirodimos et al., 
2010).  Outbreaks associated with contami-
nated water outlets in hospitals are well 
documented   (Bert et al., 1998; Pitten et al., 
2001; Aumeran et al., 2007; Cervia et al., 
2008;  Kohlenberg et al., 2010; Nagao et al., 
2011).      
 
Studies on Pseudomonas aeruginosa are very 
important because of the organism’s ever 
growing multidrug resistance (Micek et al., 
2005; Lutz and Lee, 2011).  This type of 
study particularly, surveillance in drinking, 
domestic, recreational and hospital storage 
water, and relationship with clinical infec-
tions is rare in Nigeria.  This study was de-
signed to survey different water sources for 
risk of multi-drug resistant P. aeruginosa in 
Abeokuta, south western Nigeria and to 
determine strains relatedness with clinical 
isolates in terms of plasmid DNA profile. 
   
MATERIALS AND METHODS 
Collection of Water Samples 
A total of two hundred and eighty eight 
(288) water samples were collected from 6 
different sources (‘Sachet water’, ‘bottled 
water’, swimming pool, hand-dug well, hos-
pital storage tank and community tap water) 
in Abeokuta, Nigeria at weekly intervals dur-
ing the period of 6 months (October 2011- 
March 2012).    Samples were collected into 
250 ml sterile glass bottles during the day 
between 9:00 hrs and 13:00 hrs and were 
transported to the laboratory in ice box; mi-
crobiological analysis was performed within 
4 h of collection.  
 
Isolation of Pseudomonas aeruginosa 
from water samples 
ASTM International Standard Test Method 
for Isolation and Enumeration of Pseudomo-
nas aeruginosa from Water [D 5246 - 92] 
(2004) was adopted for this study.    One 
hundred milliliter (100 ml) of each water 
sample was filtered using membrane filtra-
tion technique using a sterile 0.45-μm-pore-
size, 47 mm diameter cellulose membrane 
filter (Millipore, Bedford, MA, USA).  The 
filters were then seeded onto Centrimide 
agar and incubated at 40 o C for 24 h.       
 
Pseudomonas aeruginosa from clinical 
samples  
P. aeruginosa clinical strains isolated from 
urine, eye, wound, blood and ear samples, 
collected as part of routine diagnostic test at 
the medical laboratory of two hospitals in 
Abeokuta, Nigeria were obtained for this 
study after due ethical approval from the 
Human Research Ethics Committees. 
 
Confirmation of Pseudomonas aerugino-
sa isolates 
Isolated pure cultures of bacteria were grown 
on Nutrient Agar and confirmed as P. aeru-
ginosa using Gram staining and biochemical 
tests.  Colonies were identified using the Ber-
gey’s Manual of Determinative Bacteriology. 
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Multi-drug Resistance Testing  
Commercially available antimicrobial disc 
(Abtek Biological Ltd UK) was used to de-
termine the drug sensitivity and resistance 
pattern of the isolates to the following:  
Gentamycin (GEN) 10µg, Erythromycin 
(ERY) 15µg, Ampicillin (AMP) 10µg, Aug-
mentin (AUG) 10µg, Cotrimoxazole (COT) 
25µg, Tetracycline (TET) 30µg, Streptomy-
cin (STR) 10µg, Ciprofloxacin (CIP) 5µg, 
Cloxacillin (CXC) 5µg, Amoxicillin (AMX) 
25µg, and Cefuroxime (CXM) 30µg using 
the Kirby-Bauer disc diffusion method 
(Bauer et al., 1966).  The turbidity of the 
bacterial suspensions was compared with a 
Macfarland’s barium sulfate standard solu-
tion corresponding to 1.5 = 10 cfu/ml. The 
standardized bacterial suspension was inoc-
ulated on to Muller Hinton Agar (Lab M 
Laboratories, Mumbai, India) and left to dry 
for 10 m, before placing the antibiotic im-
pregnated discs.  
 
After incubation, the diameter of the zone 
of inhibition were measured and compared 
with zone diameter interpretative chart 
(CLSI, 2008) to determine the sensitivity 
and resistance of the isolates to antibiotics.  
Isolates resistance to multiple antibiotics 
were considered for further study. 
 
Plasmid Isolation and Profiling 
Pure isolates were inoculated on Mueller 
Hinton agar and incubated overnight.  Plas-
mid isolation was conducted using a highly 
pure isolation kit (Zyppy Plasmid Miniprep 
Kit).      Electrophoresis of the DNA was 
carried out on a 0.8% agarose gel in a 1X 
concentration of Tris-Borate-EDTA (TBE) 
buffer at a constant voltage of 100V, 60°C 
for about 1 h 30 m.  After electrophoresis, 
the gel was photographed under UV illumi-
nation.  The approximate molecular weights 
of the plasmid were determined using mark-
er with known molecular weight as stand-
ards. 
 
RESULTS 
Prevalence of Pseudomonas aeruginosa 
in water samples 
Figure 1 shows the prevalence and percent-
age distribution of Pseudomonas aeruginosa in 
different water samples.  Out of two hun-
dred and eighty eight (288) water sampled 
for P. aeruginosa; positive results were record-
ed in: 1 (2.4%) bottled water; 5(12.2%) sa-
chet water; 6(14.6%) tap water; 12(29.3%) 
well water; 9(22.0%) swimming pool and 8 
(19.5%) hospital storage tank.    
 
Pseudomonas aeruginosa load in water 
samples 
Pseudomonas aeruginosa load in the different 
water samples is shown in Table 1.  The 
highest (18.25× 103 cfu/ml) mean load of P. 
aeruginosa was observed in well water with 
values range of 16.0 -20.5× 103 cfu/ml while 
the least (3.5×103 cfu/ml) with values range 
of 2.5- 4.5 × 103 cfu/ml was observed in 
bottled water.   
 
Antibiogram of Pseudomonas aeruginosa 
strains from water samples 
Table 2 shows the antibiogram of Pseudomo-
nas aeruginosa strains from water samples. 
Overall, strains were resistant to Ampicillin 
(70.3%), Amoxicillin (58.7%), Augmentin 
(36.6%), Cefuroxime (68.3%), Ciprofloxacin 
(68.3%), Cloxacillin (90.2), Cotrimoxazole 
(70.7), Erythromycin (58.5%), Gentamycin 
(22.0%), Streptomycin (48.8%) and 
Tetracycline (53.7%). 
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Fig. 1. Prevalence of Pseudomonas aeruginosa in water  
Table 1.   Mean load of Pseudomonas aeruginosa in water samples  
Water Sources Sample size Mean 
 (x103cfu/ml) 
Range 
(x103cfu/ml) 
Standard Deviation 
(S.D) 
Sachet water 32 9.7 8.9-10.5 1.131 
Bottled water 32 3.5 2.5-4.5 1.414 
Tap water 32 14.5 10.5-18.4 5.587 
Well water 32 18.25 16.0-20.5 3.182 
Swimming pool 32 17.5 16.5-18.5 1.414 
Hospital water 128 11.7 11.0-12.4 0.909 
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Antibiogram of clinical Pseudomonas 
aeruginosa strains  
Out of 43 clinical P. aeruginosa isolates, 16 
(37.3%) was from wound, 5(11.6%) from 
blood; 9 (20.9%) each from ear swab and 
urine and 4 (9.3%) from eye swab.   Table 3 
shows the antibiogram of clinical Pseudomo-
nas aeruginosa strains. Pseudomonas aeruginosa 
strains displayed resistance to: Ampicillin 
(100%), Amoxicillin (100%), Augmentin 
(74.4%), Cefuroxime (83.7%), Ciprofloxacin 
(67.4%), Ofloxacilin (90.7%), Chlorampheni-
col (81.4%), Cloxacillin (76.7%), Gentamycin 
(74.4%), Streptomycin (76.7%), and Tetracy-
cline (90%).  
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Table 3: Antibiogram of clinical Pseudomonas aeruginosa strains 
SOURCE OF 
ISOLATE 
AMP 
10 µg 
AMX 
25 µg 
AUG 
10 µg 
CXM 
30 µg 
CIP 
5 µg 
OFL 
10 µg 
CHL 
30 µg 
CAZ 
30µg 
GEN 
10 µg 
STR 
10 µg 
TET 
30 µg 
Wound (16) 16(100) 16(100) 12(75) 14(87.5) 11(68.75) 14(87.5) 14(87.5) 10(62.5) 13(81.3) 12(75) 15(93.8) 
Blood (5) 5(100) 5(100) 5(100) 5(100) 4(80) 5(100) 5(100) 4(80) 2(40) 5(100) 5(100) 
Ear swab (9) 9(100) 9(100) 8(88.9) 6(66.7) 6(66.7) 8(88.9) 9(100) 8(88.9) 5(55.6) 6(66.7) 8(88.9) 
Urine (9) 9(100) 9(100) 4(44.4) 8(88.9) 5(55.6) 8(88.9) 7(77.8) 7(77.8) 8(88.9) 8(88.9) 8(88.9) 
Eye swab (4) 4(100) 4(100) 3(100) 3(100) 3(75) 4(100) 4(100) 4(100) 4(100) 2(50) 4(100) 
Total Overall 
resistant
(n=43) 
43(100) 43(100) 32(74.4) 36(83.7) 29(67.4) 39(90.7) 35(81.4) 33(76.7) 32(74.4) 33(76.7) 40(90) 
Value is showing the number of resistant isolates (percentage in parenthesis) 
Key: Ampicillin (AMP), Amoxicillin (AMX), Augmentin (AUG), Cefuroxime (CXM), Ciprofloxacin (CIP), Ofloxacilin 
(OFL), Chloramphenicol (CHL), ceftazidime(CAZ),  Gentamycin (GEN),  Streptomycin (STR), Tetracycline (TET)  
5. Plasmid profile of environmental and 
clinical Pseudomonas aeruginosa 
Plasmid analysis was carried out on the 84 
isolates of P. aeruginosa from different water 
sources and clinical samples in Abeokuta.   
One (2.5%) out the 41 P. aeruginosa strains 
from water, isolated from hospital storage 
tank had a plasmid with 2010bp weight size, 
while the remaining 40 strains (97.5%) had 
no plasmid band.   On the other hand, the 
clinical strains examined showed 20.93% (9 
out the 43 strains) having plasmid bands 
with molecular weight range of 2253-
23130bp while the remaining 34(79.07%) 
had no plasmid bands.   All strains with plas-
mid were resistant to between eight and elev-
en drugs (Table 4).    
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DISCUSSION 
The prevalence of multi-drug resistant P. 
aeruginosa in drinking, domestic, recreational 
and hospital water was evaluated in this 
study.  The highest prevalence of 29.3% 
was observed in well water, a source of 
drinking water in some households in Nige-
ria.   Prevalence of 12.2%, 14.6%, and 2.4% 
also occurred in sachet water, tap water and 
bottled water respectively and these are 
sources of drinking water that are consid-
ered safe for consumption in Nigeria.  The 
isolation of P. aeruginosa in drinking water 
sources is an indication of water quality im-
pairment which has been reported previous-
ly in public water supply from different 
parts of Nigeria (Itah and Akpan, 2005; Po-
poola et al., 2007; Okonko et al., 2008; Ajayi 
et al., 2008; Shittu, 2008; Odeyemi et al., 
2011; Sule et al., 2011; Muazu et al., 2012; 
Ukpong and Peter, 2012; Lateef et al., 2012;   
Adewoye and Adewoye, 2013) and from 
Neemuch city (Hirulka and Soni, 2011).     
 
Human health risks associated with exposure 
to P. aeruginosa via drinking water ingestion, 
estimated by Mena and Gerba (2009) 
showed that the risk of colonization from 
ingesting P. aeruginosa in drinking water is 
low.   The risk is slightly higher if the subject 
is taking an antibiotic resistant P. aeruginosa as 
observed in this study.   The fact that indi-
viduals on ampicillin are more susceptible to 
Pseudomonas gastrointestinal infection 
probably results from suppression of normal 
intestinal flora, which would allow Pseudo-
monas to colonize.   The effect of drinking 
contaminated water results in thousands of 
deaths every day, mostly in children under 
five years in developing countries (WHO, 
2004).   Diseases caused through consump-
tion of contaminated water and poor hygiene 
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Table 4:  Multidrug resistance and molecular weight of plasmid bearing strains 
Source 
of 
 isolates 
Number of 
antibiotics 
resistance 
                   Antibiotic resistance Plasmid 
weight 
Hospital tank 8 AMX, CXM,CIP, COT, ERY, STR, TET 22910bp 
Wound swab 8 AMX, AMP,CHL,STR, GEN, OFL, CAZ, TET 23000bp 
Wound swab 11 AMP, AMX, TET, CHL, STR, CXM, GEN, CAZ, OFL, CIP, 
AUG 
22520bp 
Wound swab 9 AMP, AMX, TET, CHL, CXM, GEN, CAZ, OFL, CIP 22910bp 
Wound swab 10 AMP, AMX, TET, CHL, STR, CXM, GEN, CAZ, OFL, CIP 22730bp 
Wound swab 10 AMP, AMX, TET, CHL, STR, CXM, GEN, CAZ, OFL, CIP 22639bp 
Wound swab 9 AMX, AMP, AUG, TET, CHL, STR, CXM, CIP, OFL 22798bp 
Wound swab 8 AMX, AMP, AUG, STR, CXM, CAZ, CIP, GEN 23000bp 
Blood 10 AMP, AMX, AUG, TET, CHL, STR, CXM, GEN, CIP, CAZ 23000bp 
Ear swab 8 AMP, AMX, AUG, TET, CHL, GEN, OFL, CIP 23130bp 
Key: Ampicillin (AMP), Amoxicillin (AMX), Augmentin (AUG), Cefuroxime (CXM), Ciprofloxacin (CIP), 
Ofloxacilin (OFL), Chloramphenicol (CHL), Cloxacillin (CXC),  Gentamycin (GEN),  Streptomycin (STR), 
Tetracycline (Tet). 
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practices are the leading cause of death 
among children worldwide, after respiratory 
diseases (WHO, 2003).   
 
In this study, the prevalence of P. aeruginosa 
in swimming pools in Abeokuta was 21.9%.  
Pseudomonas aeruginosa have also been report-
ed from swimming pools in other parts of 
Nigeria:   Portharcourt (Agbagwa and 
Young-Harry, 2012); Lagos (Bello et al., 
2012).    Outside Nigeria, similar result was 
obtained by Lutz and Lee (2011) from 
swimming pools and hot tubs showing 21% 
for P. aeruginosa.   A lower prevalence of 
16.6% and 17% in swimming pools and rec-
reational waters was observed in the Athens 
area (Rigas et al., 1998); and 4% in Switzer-
land (Moore et al, 2002).  A study from Ire-
land reported a very high prevalence of P. 
aeruginosa of 38% in swimming pools and 
73% of Jacuzzis and spas.    Varying rates of 
P. aeruginosa reflects different approaches to 
the maintenance of swimming pool waters 
(Barben, 2005).  The prevalence of Pseudo-
monas sp. in the pool may be affected by 
several factors such as the level of free chlo-
rine, the density of use, poor operation, 
construction and maintenance as well as the 
presence of large plastic inflatables (Tate et 
al., 2003).  Mena and Gerba (2009) also 
summarized that two routes appear to carry 
the greatest health risks from contacting 
water contaminated with P. aeruginosa which 
are skin exposure in hot tubs and lung ex-
posure from inhaling aerosols.    
 
The overall prevalence of drug resistance of 
Pseudomonas aeruginosa isolates was very high 
in this study.  Pseudomonas aeruginosa strains 
from water samples were all multidrug re-
sistance, showing highest resistance to clox-
acillin (90.2%) and least to amoxicillin 
(0.0%).  Swimming pool isolates had high   
resistance (100%) to ciprofloxacin and clox-
acillin.  A similar result was observed by Lutz 
and Lee (2011) where 96% of isolates from 
swimming pool tested were multidrug re-
sistant.  Clinical isolate on the other hand, 
altogether showed greater than 65% re-
sistance to all the antibiotics tested with all 
isolates showing 100% resistance to ampicil-
lin and amoxicillin.    
 
The occurrence of multidrug resistance P. 
aeruginosa strains observed in this study is 
similar to other reports across Nigeria  
(Daini et al., 2008; Ogbolu et al., 2008; 
Olayinka et al., 2009; Akanji et al. (2011), 
Okesola and Oni (2012), Akingbade et al. 
(2012), Daini and Charles-Onyeaghala 
(2012), Ehiaghe et al., 2013 and other report-
ed hospital outbreaks (Cervia et al., 2008;  
Kohlenberg et al., 2010; Nagao et al., 2011).   
In contrary to Gad et al. (2007), the clinical 
isolates of P. aeruginosa exhibited higher anti-
biotic resistance than environmental isolates.   
Out of all the 84 isolates of P. aeruginosa 
strains, 48.8% were resistant to gentamicin 
which used to be traditionally considered as 
a first-line drug against Gram negative bacte-
rial infections in the hospital setting 
(Oduyebo et al., 1997).   The use of broad 
spectrum antibiotics in hospitals exerts selec-
tive pressure on bacteria, thereby promoting 
infections by multi-drug resistant strains 
(Richard et al., 1994).  Resistance to some 
antibiotics such as ampillicin, amoxillin, 
streptomycin, tetracycline and cefuroxime 
showed an increase in comparison with pre-
vious studies in different countries 
(Friedland et al., 2005). 
 
In this study, all isolates with plasmid were 
resistant to more than seven antibiotics.  
There is no plasmid relationship between 
environmental and clinical isolates as only 1 
(2.5%) with molecular weight of 22910bp 
was observed in environmental isolates, 
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while 9 (20.9%) was observed in clinical 
isolates (molecular weight ranging from 
22010 to 23130bp).  This result is in agree-
ment with Salama et al. (2012) in a similar 
study who concluded that the simple use of 
bacterial protein electrophoresis and plas-
mid profiling ruled out the relatedness be-
tween the clinical and the contaminated wa-
ter samples.  From this study, there is also 
no relationship between plasmid occurrence 
and multidrug resistance, for all environ-
mental and clinical isolates without plasmid 
were also multidrug resistant.   This showed 
that strains inability to possess plasmid does 
not affect its ability to confer resistances to 
various antibiotics. 
 
Intrinsic antimicrobial resistance in P. aeru-
ginosa is due to low outer membrane perme-
ability, as well as an extensive efflux pump 
system.   Also, some P. aeruginosa strains ex-
hibit mutations in fluoroquinolone binding 
sites, the loss of porin channels, and in-
creased beta-lactamase or cephalosporinase 
production.  Additional resistance mecha-
nisms are acquired from plasmids and mul-
tidrug resistance that routinely develops 
through the course of a treatment regimen 
(Kato et al., 2001; Aeschlimann et al., 2003; 
Lister et al., 2009; Strateva et al., 2009).  The 
acquisition of Multidrug resistant P. aerugino-
sa is costly, both in terms of money and hu-
man suffering (Carmeli et al., 1999), and re-
sults also in higher mortality rate (Harris et 
al., 1999; Grisaru et al, 2000).    
 
CONCLUSION 
The prevalence of Multidrug resistant P. 
aeruginosa strain in water is of public health 
significance, as the source of infection is 
very important in the curtailment and con-
trol of spread of infection.  Even though, P. 
aeruginosa has been reported from different 
clinical and environmental sources, this is 
the first report on the occurrence of multi-
drug resistant strains of P. aeruginosa from 
diverse environmental sources in Nigeria.  
This calls for a serious public health concern, 
particularly for immune-compromised indi-
viduals, such as Human Immunodeficiency 
Virus (HIV) patients in the current epidemic. 
 
RECOMMENDATIONS 
The following recommendations are made 
from the findings of this study: 
Control guidelines on Pseudomonas aeruginosa 
as a potential pathogen in water sources, 
should be formulated for Nigeria similar to 
those in developed country for health care 
providers and for drinking and recreational 
water.   
 
Other genetic markers apart from plasmid 
profile should be used to investigate the ge-
netic relatedness of clinical and environmen-
tal multidrug resistant P. aeruginosa. 
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